No abstract available
MeSH terms
-
Adolescent
-
Child
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Drug Approval*
-
Glucagon-Like Peptide-1 Receptor / agonists*
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Liraglutide / therapeutic use*
-
United States
-
United States Food and Drug Administration
-
Young Adult
Substances
-
Glucagon-Like Peptide-1 Receptor
-
Hypoglycemic Agents
-
Liraglutide